The Global Outlook for Next Generation Sequencing: Usage, Preferences, & Budgets
|世界の次世代シーケンシング見通し：使用・好み・予算 The Global Outlook for Next Generation Sequencing: Usage, Preferences, & Budgets|
|出版日: 2011年10月19日||ページ情報: 英文||
Gene sequencing technology, initially semi-automated in the 1980' s, is rapidly advancing to support cutting-edge exploration into disease diagnostics and therapeutic intervention. With the ability to sequence millions of DNA segments in a single run and identify diagnostic markers for multiple species in a sample - without cloning or PCR amplification - sequencing technologies are on the cusp of a new generation. Coined “third gen,” the race for genomics tool suppliers to develop faster more cost-effective sequencing instruments is fueled by a global mission to reduce the cost of sequencing the human genome to under $1,000 US dollars. Cheaper and faster are the keywords in sequencing innovation. But new technologies don' t necessarily render old ones obsolete, as the early sequencing techniques (e.g., Sanger) still present the best solution for specific applications.
Balancing innovation with the realities of how quickly labs will adopt new platforms is the challenge for next generation sequencing (NGS) product suppliers. New technologies create excitement, but installing and learning how to incorporate new systems into ongoing research requires a desire (and commitment) from the lab. BioInformatics LLC' s upcoming report, The Global Outlook for Next Generation Sequencing: Usage, Preferences and Budgets, was designed to help NGS product suppliers move forward into uncharted territory in a strategic way so as to optimize solutions that are relevant to the research and realistic for laboratories to adopt.
This worldwide study of the academic and pharma/biotech sectors provides a market analysis of NGS and an assessment of the brand equity and brand positioning of companies providing NGS instrumentation and consumables. To better understand the current market for NGS technologies, the report includes an in-depth exploration of NGS technologies currently deployed, workflow and types of applications. To assist with competitive benchmarking, study respondents are asked to compare brands across multiple criteria (e.g. accuracy of reads, ease of use, innovation of technology, turnaround time/experiment time etc.) and rank them on value for price paid, satisfaction and gaps in product offerings. Understanding current usage and brand preferences help to identify must-have features and unmet needs, which illuminates gaps in individual vendor offerings and opportunities in the market as a whole.
For future planning purposes, the report includes average lab budgets for NGS and predicted growth in lab budgets through 2012. Purchasing drivers are delineated, and upcoming plans, criteria and funding for purchases are explored. In addition, the report provides direction from the scientists as to where the market is headed and the impact of new markets such as diagnostics and personal genomics.
The Global Outlook for Next Generation Sequencing: Usage, Preferences and Budgets was designed for next generation sequencing product suppliers who are navigating a technology frontier that has captured the imagination of researchers, healthcare providers and entrepreneurs. This report will help suppliers allocate resources to new applications & markets and to optimize current products by making them more responsive to scientists who are already engaged in the next generation of whole genome sequencing.
Most Significant Improvement to Your
Next Generation Sequencing Workflow
©2011 BioInformatics, LLC
Most Informative Sources of Next Generation
Sequencing Product Information
©2011 BioInformatics, LLC
Sources of Independent, Unbiased Research
Unlike reports from other firms that are based on an analyst' s subjective summary of information from publicly available sources, our reports are based on the results of detailed surveys of hundreds - even thousands - of scientific and medical professionals who buy your products.
Developed by a Team of Experts
Our questionnaires are developed by a multi-disciplinary team of scientists, industry veterans and market research experts with years of experience. These professionals understand that survey questions need to be asked in a way that ensures the answers will directly address the business challenges you face. Once the survey data is collected, this same team creates a unique report that presents the reader with a thorough understanding of the topic and the scientific and business implications of the results based on sophisticated statistical analytics.
Custom Analysis & Research Available
If you' d like to delve deeper into the data from a study, we can always perform custom cross-tabulations or other analysis on your behalf. We can even pose follow-up questions to respondents who answered in a particular way or conduct a custom study to extend your knowledge.
Carefully Selected Survey Participants
When others promote results from their online surveys, they fail to mention the uncontrolled nature of their broadcast email invitations. To provide you with the most valid and accurate results possible, the respondents to our surveys are members of our unique online panel - The Science Advisory Board® - which consists of more than 66,000 verified life science and biomedical professionals who have agreed to take part in our surveys, focus groups and other market research activities. These respondents are carefully selected based on their professional qualifications, market segments and geographic regions - we can even select them based on the products they use and their preferred suppliers.